Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_assertion type Assertion NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_head.
- NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_assertion wasGeneratedBy ECO_0000203 NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_provenance.
- NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_assertion wasDerivedFrom befree-20150227 NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_provenance.
- NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_assertion SIO_000772 7911242 NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_provenance.
- NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_assertion evidence source_evidence_literature NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_provenance.
- NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_assertion description "[Because of its restricted normal tissue distribution and abundant expression in the stroma of over 90% of breast, colorectal, and lung carcinomas, FAP alpha is under clinical evaluation as a target for immunodetection and immunotherapy of epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860594.RAzn4WRrm2LzupJiq6WrgbPFifyCi8WrBLwbLak9E92cI130_provenance.